What is "Nanotis"?

唾液による次世代のインフルエンザ検査

患者・医師の抱える課題を解決し、より効率的な医療を実現

No pain

Wherever

Whoever

Whenever

Team

CEO, Founder | Lisa Sakashita

M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes: Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service industry, she won MVP for top sales.

CTO | Jinsei Miyazaki

B. E., and M. E. degree from Faculty of Technology, Kyoto University.
Gust scientist of Max-Planck Institute of Bio-Physical Chemistry in 1989-1991.
1981: Joined Matsushita Electric Industries (Panasonic, as of now) and consistently kept cultivating new technology fields including immuno-chemical sensing. 2002: Established tele-healthcare based joint venture, Viterion LLC, in NY USA, and served as CTO. After return back to Japan in 2006, managed variety of medical equipments as the GM of engineering group, AA-SBU Panasonic Healthcare Co. Ltd. Transferred to Meiji Seika Pharma according to the assignment of laser technology of Photodynamic therapy against cancers in 2015.

Researcher | Yoko Nagai

As an engineer, Nagai has been engaged in general equipment analyses and drug R&D in the field of biochemistry for 12 years at major pharmaceutical companies and a food manufacturer, etc. After graduating from university, she joined a national project team of Keio University. Then, she was engaged in R&D of injectables for hepatitis C and osteoporosis at a major domestic pharmaceutical company, and assessment of adverse drug reaction cases at a foreign pharmaceutical company.
Nagai joined Nanotis due to her deep affinity with our mission concept of “Whenever, Wherever, and Whoever.”

Member of the Board | Koji Nakao

Corporate adviser of Terumo Corporation, Chairman of The Japan Federation of Medical Devices Associations, Chairman of Medical Technology Association of Japan, Director of The Japan Association for Medtech Innovation

B. L. degree from the Faculty of Law, Keio University. Nakao started his career at Terumo Corporation in 1970. Then he successively assumed the posts of Chairman & CEO of Terumo Medical Corporation (US), and Director, Vice President, and Executive Officer at Terumo Corporation. He was then elected as Chairman of the Board of the company in 2011. Since 2016, he has been the Corporate Adviser of

Scientific Founder | Michika Onoda Ph.D.

Dr. Michika Onoda is a Postdoctoral Researcher at Massachusetts Institute of Technology.

He received a Ph. D. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, President’s Award). His career includes JSPS Research Fellow DC1 (2016), Visiting Researcher at University of Minnesota (2017), JSPS Superlative Postdoctoral Fellow at Nagoya University (2019 to present), and Postdoctoral Researcher at Massachusetts Institute of Technology (2019 to present).

The target of his research is to create novel functional polymeric materials, especially in the field of the polymer gel. In his career, he won more than eighteen awards at national and international conferences including the University of Tokyo President’s Award for the outstanding research about artificial amoeba utilizing polymeric fluids. In addition

Technical Advisor | Teruyuki Nagamune, Ph. D.

B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes: RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), etc.

Collaborator | Norio Omagari M.D., M.Sc., Ph.D

National Center for Global Health and Medicine
Disease Control and Prevention Center
Director

Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke’s International Hospital as a resident and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the posts of Senior Staff and Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s Director since 2012.
In

Collaborator | Yoshida-Akimoto lab., the Univ. of Tokyo

Ryo Yoshida, Ph. D.

Dr. Ryo Yoshida is a full professor at The University of Tokyo. He received a Ph.D. degree in chemical engineering in 1993 from Waseda University, Japan. He was a research associate at Tokyo Women’s Medical University in 1993, a researcher at the National Institute of Materials and Chemical Research from 1994–1997, and an assistant professor at University of Tukuba from 1997–2000. In 2001, he moved to The University of Tokyo as an associate professor and became a full professor in 2012. He won the Society of Polymer Science, Japan Wiley Award in 2009.

LATEST NEWS

Nanotis, the UTokyo-linked start-up, raises ¥45M from Shizuoka Capital, Hamamatsu Photonics, and individual investors

Press Release Nanotis (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita), the University of Tokyo-related start-up that is developing rapid diagnostic devices for infectious diseases, has raised ¥45,000,000 JPY (~$400,000 USD) from Shizuoka Capital (Head Office: Shizuoka, Shizuoka; President: Akira Hiruma), Hamamatsu Photonics (Head Office: Hamamatsu, Shizuoka; President: Akira Hiruma), […]

DBJ Women Entrepreneurs Prize, 6th DBJ New Business Plan Competition for Women Entrepreneurs

詳細は日本政策投資銀行のプレスリリースをご覧ください。

Grand Prize, Bayer Innovation Connetion 2016

詳細はバイエル社のプレスリリースをご覧ください。

 Information 

10/15/2018

Nanotis raises ¥45M from Shizuoka Capital, Hamamatsu Photonics, and individual investors.  See more

 Information 

04/01/2018

Commenced a joint research project with Yoshida-Akimoto Laboratory of the Department of Materials Engineering, Graduate School of Engineering, University of Tokyo.

 Information 

02/01/2018

Commenced a joint research project with the Synthetic Cell Engineering Lab of the Department of Bioengineering, Graduate School of Engineering, University of Tokyo.

 Information 

01/01/2018

Our corporate advisor Koji Nakao was appointed as the External Director of Nanotis.

 Press 

11/16/2017

Our CEO, Lisa Sakashita received the DBJ Outstanding Woman Entrepreneur Award at the "6th Woman Entrepreneurs New Business Plan Competition" hosted by Development Bank of Japan (DBJ). See more

 Information 

10/01/2017

Commenced a joint preclinical research project with the Disease Control and Prevention Center of the National Center for Global Health and Medicine.

 Information 

06/12/2017

Adopted for the 4th ASAC program, an acceleration program provided by the Tokyo Metropolitan Government and Deloitte Tomatsu Venture Support.

 Press 

04/26/2017

Reported in the April 26 issue of The Japan Times.

 Press 

02/13/2017

Reported in the February 18 issue of Weekly Toyo Keizai.

 Information 

02/07/2017

Koji Nakao, the current Corporate Advisor of Terumo Corporation and Chairman of the Japan Federation of Medical Devices Associations, was appointed as a corporate advisor of Nanotis.

 Information 

02/01/2017

Commenced a joint research project with Nagamune Laboratory of the Department of Chemistry & Biotechnology, Graduate School of Engineering, University of Tokyo.

 Press 

12/29/2016

Reported in the February issue of Monthly PROJECT DESIGN.

 Press 

12/07/2016

Reported in Nikkei Digital Health.

 Event 

12/05/2016

Received a grand prize at Grants4Apps Tokyo, an open innovation program hosted by Bayer Yakuhin. See more

 Information 

09/01/2016

Commenced a joint research project with the Fujita Laboratory of the Institute of Industrial Science, University of Tokyo. (The project ended in August 2017 due to the retirement of Professor Fujita.)

 Information 

06/06/2016

Founded.


CONTACT

Your Name*

E-Mail*

Title*

Message*


Acceptance